108 related articles for article (PubMed ID: 31962142)
1. Dormant tumor cells interact with memory CD8
Flores-Guzmán F; Utikal J; Umansky V
Cancer Lett; 2020 Apr; 474():74-81. PubMed ID: 31962142
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
Umansky V; Abschuetz O; Osen W; Ramacher M; Zhao F; Kato M; Schadendorf D
Cancer Res; 2008 Nov; 68(22):9451-8. PubMed ID: 19010920
[TBL] [Abstract][Full Text] [Related]
3. Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.
Umansky V; Sevko A
Pigment Cell Melanoma Res; 2013 Jul; 26(4):457-63. PubMed ID: 23560814
[TBL] [Abstract][Full Text] [Related]
4. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
5. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.
Ramacher M; Umansky V; Efferth T
Anticancer Drugs; 2009 Nov; 20(10):910-7. PubMed ID: 19745721
[TBL] [Abstract][Full Text] [Related]
6. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
Pommier A; Audemard A; Durand A; Lengagne R; Delpoux A; Martin B; Douguet L; Le Campion A; Kato M; Avril MF; Auffray C; Lucas B; Prévost-Blondel A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13085-90. PubMed ID: 23878221
[TBL] [Abstract][Full Text] [Related]
8. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells.
Letsch A; Keilholz U; Assfalg G; Mailänder V; Thiel E; Scheibenbogen C
Cancer Res; 2003 Sep; 63(17):5582-6. PubMed ID: 14500398
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer.
Ge Y; Böhm HH; Rathinasamy A; Xydia M; Hu X; Pincha M; Umansky L; Breyer C; Hillier M; Bonertz A; Sevko A; Domschke C; Schuetz F; Frebel H; Dettling S; Herold-Mende C; Reissfelder C; Weitz J; Umansky V; Beckhove P
Cancer Immunol Res; 2019 Dec; 7(12):1998-2012. PubMed ID: 31672785
[TBL] [Abstract][Full Text] [Related]
11. GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology.
Lin GH; Snell LM; Wortzman ME; Clouthier DL; Watts TH
J Immunol; 2013 May; 190(9):4627-39. PubMed ID: 23536631
[TBL] [Abstract][Full Text] [Related]
12. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
13. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation.
Umansky V; Sevko A
Cancer Immunol Immunother; 2012 Feb; 61(2):275-282. PubMed ID: 22120757
[TBL] [Abstract][Full Text] [Related]
14. Resident memory CD8
Molodtsov AK; Khatwani N; Vella JL; Lewis KA; Zhao Y; Han J; Sullivan DE; Searles TG; Preiss NK; Shabaneh TB; Zhang P; Hawkes AR; Malik BT; Kolling FW; Usherwood EJ; Wong SL; Phillips JD; Shirai K; Angeles CV; Yan S; Curiel TJ; Huang YH; Cheng C; Turk MJ
Immunity; 2021 Sep; 54(9):2117-2132.e7. PubMed ID: 34525340
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells.
Lengagne R; Le Gal FA; Garcette M; Fiette L; Ave P; Kato M; Briand JP; Massot C; Nakashima I; Rénia L; Guillet JG; Prévost-Blondel A
Cancer Res; 2004 Feb; 64(4):1496-501. PubMed ID: 14973052
[TBL] [Abstract][Full Text] [Related]
16. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
Lengagne R; Graff-Dubois S; Garcette M; Renia L; Kato M; Guillet JG; Engelhard VH; Avril MF; Abastado JP; Prévost-Blondel A
J Immunol; 2008 Jan; 180(1):130-7. PubMed ID: 18097012
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
Mahnke YD; Schwendemann J; Beckhove P; Schirrmacher V
Immunology; 2005 Jul; 115(3):325-36. PubMed ID: 15946250
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
20. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow.
Parretta E; Cassese G; Barba P; Santoni A; Guardiola J; Di Rosa F
J Immunol; 2005 Jun; 174(12):7654-64. PubMed ID: 15944266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
